INNOVATION IN DIAGNOSTICS
Wednesday, September 28th (17h00-18h30)
- Miquel Tarón: Regulatory & Development Director, AMADIX (Spain).
- Azucena Castro: General Manager, OWL (Spain). "OWLiver, a novel non-invasive lipidomic test for diagnosis and follow-up of nafld patients"
- Javier Burgos: CEO, NEURON BIOPHARMA (Spain). "AlzTEST®, a novel tool in blood for the diagnosis of Alzheimer’s disease”
- Yemi Adesokan: Co-Founder and Chief Scientific Officer, GNUBIOTICS SCIENCES (Switzerland). "Next Frontiers in Liquid Biopsy: The micro biome and liquid biopsy"
- Artur Palet: Director of Business Development, ROCHE DIAGNOSTICS (Spain). "Roche Diagnostics, value-based innovation"
- María Luisa Villahermosa: R & D Director, GENÓMICA (Spain). “A new breakthrough technology in molecular diagnostics"